천식이 예방접종 후 항체 형성에 미치는 영향 = Asthma has an adverse effect on the production of antibody to vaccines

다국어 초록 (Multilingual Abstract)

Asthma is considered a chronic inflammatory airway disease. Mounting evidence reports that patients with asthma are at significantly higher risk of developing communicable diseases such as invasive pneumococcal disease, Haemophilus influenza, varicella, measles, pertussis and tetanus. While impaired innate immunity may play a role in increased risk of developing these infections, suboptimal adaptive immune responses have also been reported to play a role in asthmatic subjects with regard to increased risk of infections. This review discusses the currently underrecognized immunological effect of asthma on antibody to vaccines and recommends that clinicians be aware of less optimal antibody production in response to vaccines in subjects with asthma. (Allergy Asthma Respir Dis 2018;6:279-283)

참고문헌 (Reference)

1 Asher MI, "Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys" 368 : 733-743, 2006

2 Braman SS, "The global burden of asthma" 130 (130): 4S-12S, 2006

3 Griffioen AW, "The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide" 32 : 265-272, 1992

4 Podjasek JC, "The FACT score in predicting pneumococcal antibody levels in asthmatics" 52 : 370-375, 2015

5 Juhn YJ, "Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?" 134 : 247-257, 2014

6 Wi CI, "Risk of herpes zoster in children with asthma" 36 : 372-378, 2015

7 James KM, "Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?" 130 : 343-351, 2012

8 이상일, "Prevalence of Childhood Asthma in Korea: International Study of Asthma and Allergies in Childhood" 대한천식알레르기학회 2 (2): 61-64, 2010

9 Palomares O, "Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells" 278 : 219-236, 2017

10 Inghammar M, "Invasive pneumococcal disease in patients with an underlying pulmonary disorder" 19 : 1148-1154, 2013

11 Jung JA, "Influence of asthma status on serotype-specific pneumococcal antibody levels" 122 : 116-124, 2010

12 Sheen YH, "Influence of HLA-DR polymorphism and allergic sensitization on humoral immune responses to intact pneumococcus in a transgenic mouse model" 88 : 25-34, 2016

13 Juhn YJ, "Increased risk of serious pneumococcal disease in patients with asthma" 122 : 719-723, 2008

14 Kim BS, "Increased risk of herpes zoster in children with asthma: a population-based case-control study" 163 : 816-821, 2013

15 Wiertsema SP, "Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response" 25 : 306-313, 2007

16 Wills-Karp M, "Immunologic basis of antigen-induced airway hyperresponsiveness" 17 : 255-281, 1999

17 Lee HJ, "Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection" 13 : 1533-1538, 1995

18 Poland GA, "Identification of an association between HLA class II alleles and low antibody levels after measles immunization" 20 : 430-438, 2001

19 Grove DI, "Humoral and cellular immunity in asthma" 55 : 152-163, 1975

20 Yon DK, "Hepatitis B immunogenicity after a primary vaccination course associated with childhood asthma, allergic rhinitis, and allergen sensitization" 29 : 221-224, 2018

21 Kim S, "Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims database" 68 : 1435-1442, 2013

22 To T, "Global asthma prevalence in adults: findings from the cross-sectional world health survey" 12 : 204-, 2012

23 World Health Organization, "Fact sheet for asthma" World Health Organization

24 Robinson KA, "Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era" 285 : 1729-1735, 2001

25 Figueiredo CA, "Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America" 131 : 1064-1068, 2013

26 Khan AQ, "Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae" 70 : 749-761, 2002

27 Khan AQ, "Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus neumoniae in the presence of cognate CD4+ T cell help" 172 : 532-539, 2004

28 Atkinson TP, "Deficient immune response to Mycoplasma pneumoniae in childhood asthma" 30 : 158-165, 2009

29 Puga I, "B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen" 13 : 170-180, 2011

30 Yoo KH, "Asthma status and waning of measles antibody concentrations after measles immunization" 33 : 1016-1022, 2014

31 Talbot TR, "Asthma as a risk factor for invasive pneumococcal disease" 352 : 2082-2090, 2005

32 Patel AR, "Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study" 22 : 278-283, 2013

33 Yoo KH, "Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma" 31 : 499-506, 2010

34 Crotty S, "A brief history of T cell help to B cells" 15 : 185-189, 2015